Skip to main content
. 2013 May 17;3:124. doi: 10.3389/fonc.2013.00124

Figure 3.

Figure 3

Targeting oncogenic PML in acute promyelocytic leukemia. Both agents target the PML-RARα fusion protein for degradation. ATRA promotes RARα-target gene transcription to overcome the differentiation block while As2O3 induces oxidant stress and directly binds PML to cause partial differentiation and apoptosis of APL cells and more effectively eradicate leukemia-initiating cells.